The Wyatt laboratory studies the genomics of lethal prostate and bladder cancer. Their overall objective…
pthomsonAugust 2, 2022
Imprinting is a critical part of normal embryonic development in mammals, controlled by defined parent-of-origin…
pthomsonJuly 31, 2022
A University of British Columbia researcher is kicking the development of a credit-card-sized, disposable “biomedical…
pthomsonJuly 30, 2022
Antimicrobial peptides (AMPs) are a promising alternative to conventional antibiotics that could save us from the looming…
pthomsonJuly 29, 2022
Congratulations to the BC Children's Hospital Research Institute (BCCHR) and Women's Health Research Institute (WHRI)…
pthomsonJuly 29, 2022
Ellen Koch is a PhD student in Dr. Lynn Raymond’s lab, who just recently successfully defended…
pthomsonJuly 28, 2022
AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets…
pthomsonJuly 28, 2022
Among the largest predators in the country, the Grizzly bear now has another claim to…
sciencecityDecember 13, 2018
The federal government is phasing out a 30-year-old funding program known for connecting teams of…
sciencecityDecember 10, 2018
Scientists have long studied brain tissue in a search for the functional changes to the…
sciencecityDecember 7, 2018
Somewhere in Canada, 24 people have gone through a frightening experience caused by the simple act…
sciencecityDecember 7, 2018
MSFHR is implementing gender neutral peer review processes for all 2019 competitions, starting with the 2019…
sciencecityDecember 7, 2018
The prevalence of Canadians living with Crohn’s disease is growing at a rapid rate. While…
sciencecityDecember 7, 2018
The European Commission and the Canadian Institutes of Health Research have announced more than $12…
sciencecityDecember 6, 2018
AbCellera announced today its collaboration with Autolus Therapeutics plc (Autolus), a clinical stage biopharmaceutical company…
sciencecityDecember 5, 2018
